{"id":"e2a989da-eddc-5845-9aec-a1badb6896c2","stable_key":"46d15d9e-d3b5-544d-ba01-b785aa3e4f42:b1-tpk1-d71n-catalysis","predicate":"reduces-catalytic-activity-of","statement":"D71N markedly decreased recombinant human TPK1 catalytic turnover.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"f66f0491-fdac-5243-b1f6-688d724391e6","mechanism_event_label":"Disrupting an active-site residue impairs B1 activation.","subject":{"id":"f3bfde78-32fd-5fb9-9cbc-b1975ca41f75","slug":"tpk1-d71n","display_name":"Human TPK1 D71N experimental variant","entity_type_key":"protein_state"},"object":{"id":"2aa99fac-8e2a-50cb-9163-1c266796e1b6","slug":"tpk1","display_name":"Human thiamine pyrophosphokinase 1","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"f66f0491-fdac-5243-b1f6-688d724391e6","stable_key":"46d15d9e-d3b5-544d-ba01-b785aa3e4f42:b1-tpk1-d71n-catalysis-event","event_type":"biochemical_relationship","label":"Disrupting an active-site residue impairs B1 activation.","description":"D71N markedly decreased recombinant human TPK1 catalytic turnover.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"36b7c3eb-068b-500f-af1c-078829df1ecc","slug":"thiamine","display_name":"Thiamine (vitamin B1)","entity_type_key":"small_molecule"},"role":"substrate","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"58b974f1-d389-5bf6-81cd-889c44442c42","slug":"atp","display_name":"ATP","entity_type_key":"small_molecule"},"role":"substrate","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"bff427ab-35f9-59c2-bb24-fd5953bbaec2","slug":"magnesium-ion","display_name":"Mg2+","entity_type_key":"ion"},"role":"assay cofactor","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"f3bfde78-32fd-5fb9-9cbc-b1975ca41f75","slug":"tpk1-d71n","display_name":"Human TPK1 D71N experimental variant","entity_type_key":"protein_state"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"2aa99fac-8e2a-50cb-9163-1c266796e1b6","slug":"tpk1","display_name":"Human thiamine pyrophosphokinase 1","entity_type_key":"protein"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence-scope","value_text":"Recombinant enzyme","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_locator","value_text":"Abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_spans","value_text":"[{\"source_document\": \"artifacts/thiamine_transport_sources/onozuka-2003-tpk1-source-record.json\", \"source_field\": \"resultList.result[0].abstractText\", \"start_char\": 0, \"end_char\": 1438}]","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Purified His-tagged human TPK1; ATP/Mg kinetics and mutagenesis.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Engineered mutation; not an isolated clinical magnesium effect.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Thiamine research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"thiamine","display_name":"Thiamine (vitamin B1)","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Disrupting an active-site residue impairs B1 activation.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[onozuka-2003-tpk1] Steady-state kinetics and mutational studies of recombinant human thiamin pyrophosphokinase (2003). https://pubmed.ncbi.nlm.nih.gov/12953792/ DOI: 10.3177/jnsv.49.156\n[sambon-2022-tpk1] Product inhibition of mammalian thiamine pyrophosphokinase is an important mechanism for maintaining thiamine diphosphate homeostasis (2022). https://doi.org/10.1016/j.bbagen.2021.130071 DOI: 10.1016/j.bbagen.2021.130071","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Recombinant enzyme","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"77539746-cfc8-5455-af47-d956313e166b","evidence_kind":"source_excerpt","locator":"Lines 358-371","start_line":358,"end_line":371,"excerpt":"### b1-tpk1-d71n-catalysis\nD71N markedly decreased recombinant human TPK1 catalytic turnover.\nCondition category: machinery_impairment\nnutrient_topic: Thiamine research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Disrupting an active-site residue impairs B1 activation.\norganism: Homo sapiens\ntissue_or_cell_type: Recombinant enzyme\nexperimental_model: Purified His-tagged human TPK1; ATP/Mg kinetics and mutagenesis.\nlimitations: Engineered mutation; not an isolated clinical magnesium effect.\nevidence_spans: [{\"source_document\": \"artifacts/thiamine_transport_sources/onozuka-2003-tpk1-source-record.json\", \"source_field\": \"resultList.result[0].abstractText\", \"start_char\": 0, \"end_char\": 1438}]\nevidence_locator: Abstract\nevidence-scope: Recombinant enzyme\n[onozuka-2003-tpk1] Steady-state kinetics and mutational studies of recombinant human thiamin pyrophosphokinase (2003). https://pubmed.ncbi.nlm.nih.gov/12953792/ DOI: 10.3177/jnsv.49.156\n[sambon-2022-tpk1] Product inhibition of mammalian thiamine pyrophosphokinase is an important mechanism for maintaining thiamine diphosphate homeostasis (2022). https://doi.org/10.1016/j.bbagen.2021.130071 DOI: 10.1016/j.bbagen.2021.130071","model_system":"Purified His-tagged human TPK1; ATP/Mg kinetics and mutagenesis.","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [onozuka-2003-tpk1] Steady-state kinetics and mutational studies of recombinant human thiamin pyrophosphokinase (2003). https://pubmed.ncbi.nlm.nih.gov/12953792/ DOI: 10.3177/jnsv.49.156; [sambon-2022-tpk1] Product inhibition of mammalian thiamine pyrophosphokinase is an important mechanism for maintaining thiamine diphosphate homeostasis (2022). https://doi.org/10.1016/j.bbagen.2021.130071 DOI: 10.1016/j.bbagen.2021.130071","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"158d2c03-ac8c-589f-8270-c468165ae346","stable_key":"import-46d15d9e-d3b5-544d-ba01-b785aa3e4f42","title":"Thiamine: mechanisms, deficiency and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"f376512fb3310141315548015b387833e3af45146e73fb73cd02cee20e4ddb9c","revision_id":"53bc5eda-dec8-58cc-a56f-a9eb4ab036ef","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}